Cannabidiol prescribing in the United States: An analysis of real-world data
Background: Off-label prescribing of Epidiolex® (pharmaceutical cannabidiol) comes with both potential benefits and risks for patients. The aims of this study were to: (1) identify the percentage of people prescribed Epidiolex® who do not have diagnostic indications for Epidiolex® (Lennox Gastaut Sy...
Saved in:
| Main Authors: | Binx Yezhe Lin, Chloe Lessard, Yifan Li, Lisa Gong, Ruth Ling, Pallawi Jyotsana, Jacob Steinle, Jacob T. Borodovsky, Fábio A. Nascimento, Kevin Y. Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Drug and Alcohol Dependence Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772724624000878 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patterns of cannabidiol use among marijuana users in the United States
by: Ji-Yeun Park
Published: (2025-02-01) -
Cannabis tolerance reduces symptom relief
by: Sarah S. Stith, et al.
Published: (2025-06-01) -
Intraperitoneal delivery of cannabidiol (CBD) and Δ9-tetrahydocannabinol (THC) promotes papillomavirus infections in athymic nude mice
by: Sarah A. Brendle, et al.
Published: (2025-06-01) -
3D Printed Bigel: A Novel Delivery System for Cannabidiol-Rich Hemp Extract
by: Anna Gościniak, et al.
Published: (2024-11-01) -
Perceptions of Patient and Surgeon Marijuana Use: A Survey Study of Upper-Extremity Patients
by: Andrew Cross, MD, et al.
Published: (2025-03-01)